CERS vs PACB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

CERS

41.7
AI Score
VS
CERS Wins

PACB

31.6
AI Score

Investment Advisor Scores

CERS

42score
Recommendation
HOLD

PACB

32score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CERS PACB Winner
Revenue 168.82M 116.75M CERS
Net Income -5.13M -90.86M CERS
Net Margin -3.0% -77.8% CERS
Operating Income -1.83M -89.97M CERS
ROE -6.8% 148.0% PACB
ROA -2.5% -12.6% CERS
Total Assets 204.73M 721.10M PACB
Cash 16.35M 55.91M PACB
Current Ratio 1.96 4.62 PACB
Free Cash Flow -4.40M -123.47M CERS

Relative Price Performance (Last 90 Days)

CERS 1M: -12.3% · 3M: -34.1% PACB 1M: +0.0% · 3M: +73.0%

Current Technical Phase

CERS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.9%), weak momentum, RSI 38

RSI (14): 37.5 · Price: $1.97

PACB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 43.7 · Price: $1.99

Fundamentals Snapshot

Metric CERS PACB
Market Cap — —
Forward P/E 141.3 -5.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.3%
Operating Margin 0.0% -0.9%
EPS -0.04 -0.42
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CERS is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.